Vanadis NIPT system is an automated cell-free DNA testing platform designed to make noninvasive prenatal testing accessible to more women – and more cost-effective for your laboratory.
Products may not be licensed in accordance with the laws in all countries, such as the United States and Canada. Please check with your local representative for availability.
Based on a breakthrough in advanced genetic analytics, Vanadis® NIPT system is the only NIPT screening platform to enable targeted cfDNA analysis without next-generation sequencing or PCR, instead directly capturing target fragments and labeling them for counting. A proprietary nanofilter plate then captures labeled molecules for imaging, eliminating the need for data-intensive steps such as DNA sequencing, microarrays, and microfluidics.
With Vanadis® NIPT system technology, all the critical steps are automated, starting with pipetting steps to reduce manual errors. Plasma volumes are monitored by camera to avoid contamination by the buffy coat, and samples and reagents are barcoded for complete tracking throughout the workflow. A system software guides you through the process, with user-friendly touchscreens, and enables remote workflow management for ease of use.
The Vanadis® NIPT system is used for the screening for the risk of trisomy 21, 18, and/or 13.
It is a high-precision NIPT platform designed to improve the access to NIPT to more women and reduce the no-call rate in order to improve the overall performance of the screening program.
Vanadis® NIPT system includes system software and trusted LifeCycle™ software, the complete data management solution for prenatal screening laboratories. With a simple and flexible user interface and a performance monitoring dashboard that enables access from any current web browser, the software provide the reliability and support laboratories need.
